Reducing matrix effects [Bioanalytics]

posted by Ohlbe – France, 2018-10-01 17:20 (885 d 19:06 ago) – Posting: # 19356
Views: 2,042

Dear ElMaestro,

» is there any method published anywhere which can be realistically thought to have no matrix effect?
» Not just absence of mentioned effect, but truly verified absence of one and how would one go about proving it?

Define "no matrix effect". Same as concentration = 0: truly 0, or BLQ ? No matrix effect, or negligible ? Considering the analytical variability, I would consider it strictly impossible to demonstrate 0.000 matrix effect.

» If you had a gun pointed to your head and someone asks you to develop an LC-MS/MS method without matrix effect for, say, Duloxetine or Simvastatin where would you start?

Our Father who art in heaven...

I would start with:

  1. using matrix obtained the same way as subject samples (vacutainers, not commercial plasma collected in blood collection bags full of plasticisers)
  2. a real, proper sample cleaning (SPE or LLE, with a real development to really clean up, without too much loss in recovery. For instance, MTBE usually gives you a very good recovery of your drug... but also of quite a lot of things you'd like to get rid of)
  3. a real chromatography (not a 90 seconds run on a 30 mm column)
  4. comparing APCI and ESI. APCI is supposed to be less sensitive to matrix effects. Unfortunately, it is also less sensitive, full stop. May be problematic if a very low LLOQ is required (would not work for a number of the molecules you're working on).

And that's if I limit the definition of matrix effects to differences in detector response. You could expand the definition to include differences in recovery.


Complete thread:

 Admin contact
21,366 posts in 4,462 threads, 1,493 registered users;
online 16 (0 registered, 16 guests [including 5 identified bots]).
Forum time: Friday 11:27 CET (Europe/Vienna)

The statistician has no magic touch by which
he may come in at the stage of tabulation
and make something of nothing.    W. Edwards Deming

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz